Treatment Trends for 2017: PARP Inhibitors and Immunotherapy for Gynecologic Cancers - 102134

Spotlight
Video

Treatment Trends for 2017: PARP Inhibitors and Immunotherapy for Gynecologic Cancers

SGO2017 has 36 videos Subscribe Here

Loading........
Description: Elizabeth Swisher, MD of University of Washington Medical Center discusses the treatment trends for ovarian cancer for 2017. She highlights the use of FDA-approved PARP inhibitors, immunotherapy, and even combination therapy with PARP inhibitors and immunotherapy. This was recorded at the 2017 Society of Gynecologic Oncology (SGO)’s Annual Meeting on Women’s Cancer® in National Harbor, MD.
Shared By : SGO2017
Posted on : 03/31/17
Added : 2 years ago
Category : Ovarian Cancer